Clinical Trial | The Truth About Skin Care

{ Tag Archives } Clinical Trial

Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections

Main Category: Dermatology
Also Included In: Clinical Trials / Drug Trials; Infectious Diseases / Bacteria / Viruses
Article Date: 01 Sep 2010 – 6:00 PDT

email to a friend printer friendly opinions
<!– rate article
The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa [...]

Also tagged Biopharma, Broad Spectrum, Clinical Trials, Cross Resistance, Drug Resistant Bacteria, Gram Positive Bacteria, Gunnar, Hungarian Authorities, Infectious Diseases, Mechanism Of Action, Novel Drug, Patient Group, Pharmaceutical Company, Phase Iia, Rate Article, Regulatory Authorities, Resistant Staphylococcus Aureus, Skin Bacteria, Skin Infections

2010 09 01 Skin Care News Comments Off

Vicept Therapeutics Announces Positive Clinical Study Results Of V-101 For The Treatment Of The Erythema Of Rosacea

Main Category: Dermatology
Also Included In: Clinical Trials / Drug Trials; Pharma Industry / Biotech Industry
Article Date: 06 Aug 2010 – 4:00 PDT

email to a friend printer friendly view / write opinions
<!– rate article

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic [...]

Also tagged Active Ingredient, Bioavailability, Biotech Industry, Chief Executive Officer, Chronic Skin Condition, Endpoints, Friendly View, Leyden, Pharmacodynamic, Professor Emeritus, Rate Article, Safety Profile, Side Effect Profile, Significant Improvement, Study Participants, Sunburn, Therapeutics Inc, Topical Cream, Unive

2010 08 06 Skin Care News Comments Off

Nitric BioTherapeutics Initiates Phase II Onychomycosis Study

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Dermatology; Clinical Trials / Drug Trials
Article Date: 16 Jul 2010 – 1:00 PDT

email to a friend printer friendly view / write opinions
<!– rate article

Nitric BioTherapeutics, Inc. (Nitric Bio) announced the initiation of a Phase II clinical trial of the [...]

Also tagged Biotherapeutics, Chairman Of The Board, Controlled Trial, Delivery System, Executive Chairman, Friendly View, Fungus, Industry Expert, Infectious Diseases, Interim Analysis, Iontophoresis, Onychomycosis, Oral Drug, Phase Ii, Quaker Bioventures, Rate Article, Skin And Nails, Terbinafine, Treatment Option

2010 07 16 Skin Care News Comments Off

Morria Biopharmaceuticals Plc. Announces Initiation Of Its Phase II Study In Contact Dermatitis Patients Using MRX6, A Novel Anti-Inflammatory Drug

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today the initiation of its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6. The double-blind, placebo-controlled study of up to 80 contact dermatitis patients will take place at the Hadassah Hospital in Israel…

Also tagged Anti Inflammatory Drugs, Biopharmaceutical Company, Biopharmaceuticals, Contact Dermatitis, Dermatitis, Double Blind Placebo, Hadassah Hospital, Inflammatory Drug, Initiation, Israel, Non Steroidal Anti Inflammatory Drugs, Phase Ii, Plc

2010 04 23 Skin Care News Comments Off

PharmaSurgics To Extend Phase II Clinical Trial For Prevention Of Post-Surgical Adhesions

PharmaSurgics in Sweden AB – part of the Karolinska Development dermatology and wound healing company “Pergamum” has received approval from the Danish Medicines Agency and the Independent Ethics Committee to begin a phase II clinical trial in Denmark…

Also tagged Danish Medicines Agency, Denmark, Dermatology, Ethics Committee, Independent Ethics, Pergamum, Phase Ii, Prevention, Sweden, Wound Healing

2010 04 13 Skin Care News Comments Off

Successful Phase IIa Clinical Trial Evaluating DeOvo, Investigational Proprietary Drug, New Topical Treatment For Head Lice Infestation

Hatchtech Pty Ltd confirms a successful Phase IIa clinical trial evaluating DeOvo, an investigational proprietary drug being developed as a new topical treatment for head lice infestation. The double-blind placebo-controlled study was conducted in 30 heavily infested adult subjects…

Also tagged Adult Subjects, Double Blind Placebo, Head Lice Infestation, Phase Iia, Pty Ltd, Topical Treatment, Treatment For Head Lice

2010 03 25 Skin Care News Comments Off

Molecular Insight Pharmaceuticals Advances Solazed(TM) For Malignant Melanoma Into Phase 1 Clinical Trial

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) today announced the initiation of a Phase 1 clinical trial of Solazed™ (Ioflubenzamide I-131), the Company’s targeted radiotherapeutic drug candidate for treatment of malignant metastatic melanoma…

Also tagged Drug Candidate, Initiation, Insight, Malignant Melanoma, Melanoma, Metastatic Melanoma, Mipi, Nasdaq, Pharmaceuticals Inc, Phase 1

2010 03 23 Skin Care News Comments Off

VBL Therapeutics Initiates Phase 2 Clinical Trial Of VB-201 In Patients With Psoriasis

VBL Therapeutics announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis…

Also tagged Efficacy, Immune Response, Initiation, Lead Compound, Lead Treatment, Phase 2, Psoriasis, Reduce Inflammation, Safety Study, Vb

2010 01 08 Skin Care News Comments Off

Pharmasurgics To Begin Phase II Clinical Trial For Prevention Of Post-Surgical Adhesions

Pharmasurgics AB – part of the Karolinska Development dermatology and wound healing company “Pergamum” announced that Pharmasurgics has received approval from the Swedish Medical Products Agency to begin a Phase II clinical trial…

Also tagged Dermatology, Medical Products Agency, Pergamum, Phase Ii, Prevention, Surgical Adhesions, Swedish Medical Products Agency, Wound Healing

2009 12 04 Skin Care News Comments Off

Dermagen Reports Successful Phase I/IIa Clinical Trial For Atopic Dermatitis

DermaGen AB – part of the Karolinska Development dermatology and wound healing company “Pergamum” announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis…

Also tagged Amp, Atopic Dermatitis, Clinical Phase, Dermagen, Dermatitis, Dermatology, Novel, Peptide, Promising Results, Wound Healing

2009 12 03 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Clinical Trial

Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections

Vicept Therapeutics Announces Positive Clinical Study Results Of V-101 For The Treatment Of The Erythema Of Rosacea

Nitric BioTherapeutics Initiates Phase II Onychomycosis Study

Morria Biopharmaceuticals Plc. Announces Initiation Of Its Phase II Study In Contact Dermatitis Patients Using MRX6, A Novel Anti-Inflammatory Drug

PharmaSurgics To Extend Phase II Clinical Trial For Prevention Of Post-Surgical Adhesions

Successful Phase IIa Clinical Trial Evaluating DeOvo, Investigational Proprietary Drug, New Topical Treatment For Head Lice Infestation

Molecular Insight Pharmaceuticals Advances Solazed(TM) For Malignant Melanoma Into Phase 1 Clinical Trial

VBL Therapeutics Initiates Phase 2 Clinical Trial Of VB-201 In Patients With Psoriasis

Pharmasurgics To Begin Phase II Clinical Trial For Prevention Of Post-Surgical Adhesions

Dermagen Reports Successful Phase I/IIa Clinical Trial For Atopic Dermatitis

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: